Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Tumor-destroying sound waves receive FDA approval for liver
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2495)
•••
Comment by Eoganachton Oct 17, 2023 8:25pm
173 Views
Post# 35688191

RE:RE:RE:Tumor-destroying sound waves receive FDA approval for liver

RE:RE:RE:Tumor-destroying sound waves receive FDA approval for liver Thanks for the update, Pandora 

Pandora wrote:
That patent has been given a Notice of Allowance (July 19, 2023) i.e. 'approval' -- and the fee was requested to trigger the issue of the patent. Payment of the fee has been acknowledged (Sept. 21, 2023) so it should be a short time to have an issue date announced.

The patent process is slow but it usually does not take that long from Notice of Allowance to 'Issue' -- in my opinion -- from those that I have followed. Notice of Allowance was back in mid-July. ??

17/192,569 | T1081/20043:

SONODYNAMIC THERAPY USING SONODYNAMICALLY ACTIVATED COORDINATION COMPLEXES OF TRANSITION METALS AS SENSITIZING AGENTS

Application #

17/192,569

Confirmation #

5826

Attorney Docket #

T1081/20043

Patent #

-

Filing or 371 (c) date

03/04/2021

Status

Publications -- Issue Fee Payment Verified 09/21/2023
 

Showing 5 of 53 entries
 
 


 




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities